Human Metabolome Technologies, Inc.

6090.T
Diagnostics & Research
2026/09/18 Updated
Market Cap: $20.7M (¥3.3B)
Stock Price: $3.85 (¥605)
Exchange Rate: 1 USD = ¥156.99

Notice Regarding Share Treasury Stock Disposal as Restricted Stock for Our Employees

Aimed at implementing an employee-restricted stock grant program, granting 7,589 shares at 4,652,057 yen to 48 employees. Payment due date: 2026/12/18. Restriction period: from 2026/12/18 to 2031/12/17. Conditions for acquiring restricted shares free of charge and handling during corporate reorganizations are specified, with the transaction conducted via in-kind contributions and exchange of monetary claims.

Importance:
Page Updated: September 18, 2026
IR Disclosure Date: September 18, 2026

Key Figures

  • 7,589 shares
  • 4,652,057 yen
  • 613 yen
  • 2026年12月18日

AI要約

Overview of the program

The program is designed to enhance employee engagement and management participation by granting restricted stock to 48 eligible employees, with the monetary claim of 4,652,057 yen provided as consideration for the stock grant. The shares are issued at 613 yen each, with a transfer restriction period set from 2026/12/18 to 2031/12/17.

Conditions and administration of transfer restrictions

Conditions for application of transfer restrictions include length of service, status of employment, absence of disqualifying acts, and other requirements aligned with the program's purpose. The grant agreement includes transfer restrictions as well as prohibitions on disposition for a certain period and a provision for free acquisition. Share management is conducted through Nomura Securities' dedicated account in accordance with the contract.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Human Metabolome Technologies, Inc.

Company overview · Stock price · Financial data · All IR

View company page →